Prot #NU 20B03: Enrichment, Culturing, Characterization and Drug Sensitivity Testing of Circulating Tumor Cells (CTCs) from Patients with Stage IV Breast Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date2/10/212/10/24

Funding

  • ANGLE Europe Limited (Prot #NU 20B03)